Aaron is a senior research consultant for Advisory Board, currently leading a team researching the cross-industry impact of issues related to caring for an aging population.
Before joining Advisory Board's cross-industry team, Aaron worked on dynamics in the payer landscape for the health plan research team. His expertise includes pharmaceutical spend, with a special focus on the financial impact of emerging gene and cell therapies.
Aaron was previously with the NEWDIGS consortium at MIT, where he worked on developing innovative, private-side financing solutions for gene and cell therapies. He holds a PhD from the University of Chicago in modern European history.
Create your free account to access 2 resources each month, including the latest research and webinars.
You have 2 free members-only resources remaining this month remaining this month.
1 free members-only resources remaining this month
1 free members-only resources remaining this month
You've reached your limit of free monthly insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free monthly insights